Ovalbumin Solution (6 mg/mL) - BioReagent

Cat. No.: O1528797
Disponível para encomenda
GRAU & PUREZA BioReagent ? BioReagent grade — tested suitable for life-science and molecular-biology use. Use for cell culture, assays, and biochemical work needing biological compatibility.
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Tamanho
USA
Alemanha (EU)*
Preço
Qtd
10ml
O1528797-10ml
Sob encomenda · 8–12 semanas
24,90US$
Enter a quantity for the sizes you want to add.

Visão geral

Ovalbumin Solution (6 mg/mL) is mainly composed of ovalbumin and physiological saline.

Especificações

Especificações e pureza
BioReagent
Condições de armazenamento de armazenamento
Store at -20°C
Enviado em
Ice chest + Ice pads
Este produto requer transporte de cadeia fria. Serviços terrestres e outros serviços econômicos não estão disponíveis.
Grau
BioReagent
Product Line
Produtos biológicos

Dados avançados

Certificados(CoA,COO,BSE/TSE e Mapa de Análise)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculadoras de soluções
Revisões

Avaliações dos Clientes

Application Protocols

Tested applications, recommended working dilutions, and lot-specific protocols are Not specified for this item; refer to the product datasheet/CoA.

General protocols are intentionally not provided here because this section is restricted to product-validated instructions. For literature-based use cases (e.g., ELISA blocking, conjugation, or antigen coating), consult peer-reviewed protocols and validate conditions with small-scale pilots using this specific lot.

Biological Roles
  • Source and function (literature/general): Ovalbumin is the predominant protein in chicken egg white. Although classified among serpins, it lacks classical protease-inhibitory activity and is believed to function primarily as a nutrient/storage protein. It is a well-characterized model antigen in immunology and protein chemistry.

  • Structural/biochemical characteristics (literature/general):

    • Monomeric glycoprotein (~42–45 kDa) with one N-linked glycan, contributing to microheterogeneity and a pI around 4.5–4.7.
    • Exhibits the serpin fold but does not undergo the inhibitory conformational trapping typical of inhibitory serpins.
    • Undergoes age/processing-related conversion to S-ovalbumin, altering stability and isoelectric properties.
  • Laboratory relevance (literature/general):

    • Extensively used as a reference antigen in antigen-processing/presentation studies, tolerance/activation models, and for standardizing immunoassays.
    • Serves as a benchmark in protein folding/aggregation, thermal denaturation, and gelation studies due to its well-documented transitions.
  • Enzymatic/chemical sensitivities (literature/general):

    • Susceptible to proteolysis by broad-spectrum proteases; glycan can be trimmed by PNGase F or periodate-oxidized for conjugation.
    • Denatures with heat, extremes of pH, or chaotropes; refolding/renaturation depends on conditions.

This section summarizes general biological knowledge of ovalbumin; it does not reflect additional purification or functional attributes of this specific item, which are Not specified for this item; refer to CoA/Spec Sheet.

Buffer Applications

Ovalbumin is not a buffering agent and is not used to define pH. However, it is frequently included in aqueous buffers as a functional additive (literature/general):

  • Blocking/stabilizing protein: 0.1–1% w/v OVA is commonly used to block nonspecific binding in ELISA, western blotting, immunohistochemistry, and flow assays; it can stabilize enzymes/antibodies by occupying surfaces and providing a protein matrix.
  • Carrier in diluents: Added to antibody or antigen diluents to improve stability and reduce adsorption losses, particularly at low nanogram-per-mL levels.
  • Considerations:
    • Avoid use when anti-egg proteins are present in the system (potential cross-reactivity) or when animal-origin–free workflows are required.
    • Buffer components containing primary amines (e.g., Tris) can interfere with subsequent amine-targeted conjugations to OVA.

Item-specific buffer composition, pH, and any preservatives in this product are Not specified for this item; refer to CoA/Spec Sheet before incorporating into sensitive assays.

Green Alternatives

Green chemistry considerations for a protein solution focus on cold-chain optimization, solvent minimization, and waste reduction rather than substitution of the active component.

  • Potential greener choices (contextual):

    • Lyophilized ovalbumin (if available) to reduce refrigerated shipping mass/volume and allow reconstitution in application-specific buffers (less waste from buffer exchange).
    • Use of reusable cold packs and consolidated shipments to minimize packaging waste and emissions.
    • Replace organic solvent–intensive conjugation routes with aqueous click-like chemistries (e.g., oxime ligation, SPAAC) where compatible, reducing VOCs.
  • Comparison (general):

    • Aqueous OVA solution vs lyophilized OVA:
      • Pros (solution): Ready-to-use, no dissolution variability.
      • Pros (lyophilized): Lower shipping footprint, longer ambient resilience pre-reconstitution, buffer flexibility; fewer cold-chain risks.
      • Trade-offs: Lyophilizates require validation of reconstitution and may differ in aggregation state without proper excipients.
  • Waste minimization:

    • Plan aliquots to avoid multiple freeze–thaw cycles and product loss.
    • Employ micro-scale conjugations/assays to reduce reagent use and biohazardous waste.

Note: Item-specific formulation details (stabilizers, cryo-/lyoprotectants) are Not specified for this item; review CoA/Spec Sheet when designing greener workflows.

Pharmaceutical Uses

This product is designated For research use only and is not intended for human or veterinary applications.

  • Formulation/manufacturing context (literature/general):

    • Ovalbumin is used in research and development as a model protein to study formulation stability (aggregation, adsorption, interfacial behavior) and as a process surrogate for protein therapeutics in unit operations (filtration, chromatography method development).
    • It can serve as a carrier protein for hapten conjugates during early-stage immunogen design and assay development.
    • As a protein standard, it is used to calibrate chromatographic separations (SEC) and electrophoresis.
  • Regulatory status: No pharmacopeial status is claimed for this catalog item. Any GMP, sterility, endotoxin, residual solvent, or viral safety attributes are Not specified for this item; refer to CoA/Spec Sheet if such information is required for preclinical manufacturing research.

  • Excipient/processing aid use: In non-clinical research, OVA may function as a stabilizer or test excipient in formulation screening; suitability must be verified experimentally. For clinical or manufacturing uses, source, quality, and regulatory compliance must be established separately and are outside the scope of this product.

Physical Properties
  • Supplied form: Aqueous solution at 6 mg/mL.
  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Concentration: 6 mg/mL (item-specific).
  • Buffer composition, pH, excipients, preservatives: Not specified for this item; refer to CoA/Spec Sheet.
  • Density, refractive index, osmolality: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility (literature/general): Ovalbumin is highly soluble in water and physiological buffers; solubility decreases near its pI (~4.5–4.7). High ionic strength and neutral to slightly basic pH typically favor solubility.
  • Aggregation/thermal behavior (literature/general): OVA denatures/aggregates upon heating (onset typically >60–70 °C depending on pH/ionic strength); can form heat-set gels. Sensitive to extreme pH, organic denaturants (urea, guanidine), and strong oxidants.
  • Spectral properties (literature/general): UV absorbance at 280 nm typical of proteins containing Trp/Tyr; quantitative extinction coefficients vary by source/preparation and are not specified here—refer to CoA/Spec Sheet for item-specific A280–concentration relations, if provided.
  • Isoelectric point (literature/general): ~4.5–4.7; precipitation risk near this pH.

Notes: For exact physicochemical specifications and any stabilizers present in this catalog item, consult the CoA/Spec Sheet. Avoid assuming small-molecule style constants (bp/mp) for proteins.

Quality and Grades
  • Item-specific grade: BioReagent (as listed).

    • Meaning (general): BioReagent grade denotes suitability for common biological research applications (e.g., assay development, immunochemistry, conjugation), typically implying low bioburden and controlled manufacturing suitable for life-science workflows. However, exact specifications (endotoxin, bioburden, purity, preservative content) are manufacturer- and lot-dependent.
  • What is specified for this item:

    • Concentration: 6 mg/mL aqueous solution.
    • Additional specifications (purity %, endotoxin, host origin confirmation, glycoform profile, UV cutoff, preservatives): Not specified for this item; refer to CoA/Spec Sheet.
  • Practical implications:

    • For conjugation and immunoassay uses, buffer components (e.g., amines, primary amine-containing stabilizers, or preservatives) can interfere with carbodiimide/NHS chemistries and mass spectrometry. Since the buffer is not disclosed here, verify compatibility before use.
    • For cell culture or in vivo research, endotoxin and sterility are critical; these parameters are Not specified for this item and should be confirmed by CoA/Spec Sheet or tested in-house if required.
  • Documentation: Request lot-specific CoA, SDS, and (if needed) statements on animal origin, adventitious agents, and allergen handling controls.

Reaction and Applications
  • Typical research applications (literature/general):

    • Model antigen in immunology for antigen processing/presentation studies; widely used with defined peptides (e.g., OVA-derived epitopes) in T-cell assays.
    • Carrier protein for hapten conjugation to generate immunogens and for assay development (e.g., OVA–hapten conjugates for ELISA/SPR).
    • Blocking/stabilizing agent in immunoassays and biosensors; alternative to BSA for certain targets.
    • Calibration standard in protein quantification (e.g., standard curves for Bradford/BCA) and in SEC calibration (apparent MW ~43 kDa).
    • Template for nanoparticle/protein–polymer conjugates; heat-induced gelation studies.
  • Practical chemistry notes (general):

    • Amine-targeting: NHS-esters, isothiocyanates, and sulfo-NHS chemistries label ε-lysines and the N-terminus. Work at pH 7.5–8.5, amine-free buffers (e.g., bicarbonate or phosphate without Tris/glycine).
    • Carboxyl-targeting: EDC or EDC/NHS coupling to introduce amide linkages; activate in MES (pH 4.5–6.0), then couple near neutral pH.
    • Thiol-targeting: Native OVA contains limited free thiols; reduction may expose reactive cysteines but can perturb structure. Maleimide chemistry requires pH ~6.5–7.5.
    • Glycan-directed: Periodate oxidation of N-glycans enables oxime/hydrazone ligations (handle with care to avoid backbone oxidation).
  • Handling tips:

    • Maintain cold chain; minimize freeze–thaw (aliquoting recommended).
    • Confirm buffer composition to avoid conjugation quenching (e.g., Tris, azide).
    • Assess degree of labeling (DOL) by UV–Vis or MS when feasible; verify antigenicity post-modification by immunoassay.

Item-specific buffer, preservatives, and stabilizers are Not specified for this item; consult the CoA/Spec Sheet before sensitive chemistries.

Reaction Conditions

General, literature-based guidance for common OVA modifications; adjust to your system and verify with small-scale pilots. Item-specific buffer/preservatives are Not specified for this item; refer to CoA/Spec Sheet.

  • NHS-ester labeling (amines):

    • Buffer: Amine-free (e.g., 50–100 mM sodium bicarbonate or phosphate, pH 7.5–8.5).
    • Temperature/time: 4–25 °C, 0.5–2 h; protect from light for fluorophores.
    • Stoichiometry: Start with 2–10 equiv per accessible amine; optimize to control DOL.
    • Quench: Ethanolamine or Tris after reaction (if compatible with downstream use).
  • EDC/NHS carboxyl coupling:

    • Activation: 25–100 mM MES, pH 4.5–6.0 with EDC (and NHS or sulfo-NHS) for 5–30 min.
    • Coupling: Adjust to pH 7.0–7.5 with the amine-bearing partner for 0.5–2 h at 4–25 °C.
  • Maleimide–thiol coupling (if free thiols available/generated):

    • Buffer: pH 6.5–7.2, degassed; avoid primary amines at high concentrations.
    • Reducing agents: Use TCEP (non-thiol) if reduction is required; avoid excess DTT/βME which compete with maleimides.
  • Glycan oxidation and oxime/hydrazone ligation:

    • Oxidation: 1–10 mM NaIO4 on ice/dark for minutes; immediately desalt.
    • Ligation: pH 4.5–6.5 with aniline catalyst for oxime formation; NaBH3CN for reductive amination where appropriate.
  • Purification/cleanup: Desalting columns (NAP/PD), dialysis, or SEC; verify recovery and aggregation by UV–Vis, SDS-PAGE, or DLS.

These conditions are representative literature values and not product specifications.

Safety and Handling
  • GHS/CLP status for this item: Not specified for this item; refer to the SDS for authoritative classification, pictograms, and H-statements.
  • Allergenicity (literature/general): Ovalbumin is a major egg allergen and may cause allergic reactions upon inhalation, skin contact, or ingestion in sensitized individuals. Handle powders/aerosols in appropriate containment; avoid generating droplets/aerosols with solutions.
  • General PPE: Lab coat, nitrile gloves, and safety glasses. Use a certified biosafety cabinet for procedures that may create aerosols. Wash hands after handling.
  • Storage incompatibilities (general): Avoid strong oxidizers and extremes of pH. Do not mix with proteases unless intended; proteolysis can degrade the protein. Avoid microbial contamination.
  • Special risks: Repeated freeze–thaw can cause aggregation and loss of activity/antigenicity. Preservatives (e.g., sodium azide) may or may not be present—Not specified for this item; refer to CoA/Spec Sheet/SDS.
  • First-aid overview (general):
    • Inhalation: Move to fresh air; seek medical attention if symptoms persist.
    • Skin/eye contact: Rinse with water for several minutes; remove contaminated clothing; seek medical attention if irritation develops.
    • Ingestion: Rinse mouth; seek medical advice.
  • Spill response (general): Absorb small spills with inert material; clean with aqueous detergent; decontaminate surfaces; avoid aerosolization. Dispose of according to institutional and local regulations.
  • SDS: Always defer to the product-specific SDS for definitive hazard, handling, and disposal guidance.
Solvent Selection

This product is supplied as an aqueous protein solution; traditional solvent selection for organic reactions is not typically applicable. Key considerations relate to buffer compatibility and downstream application requirements.

  • Polarity/miscibility (general): OVA is water-soluble; it is insoluble in most neat organic solvents. It tolerates typical biological buffers (phosphate, HEPES, Tris) within moderate ionic strength.
  • Buffer compatibility (general):
    • Conjugation with NHS-esters: Prefer amine-free buffers (e.g., PBS without primary amines) at pH ~7.5–8.5.
    • Carbodiimide (EDC) coupling: Activation often at pH ~4.5–6 (MES buffer), followed by coupling near neutral pH.
    • Avoid high concentrations of denaturants (urea, guanidine) or detergents unless denaturation is intended.
  • Additives that can interfere (general): Tris, glycine, ammonium salts, and azide can quench certain conjugation reactions or enzymes; metal chelators can affect metalloprotein assays.
  • When to choose alternatives: If organic compatibility or higher thermal stability is required, consider using carrier proteins like BSA or synthetic polymers (e.g., PEG) depending on the application; for solvent-critical workflows, lyophilized OVA (if available) offers buffer flexibility.

Item-specific buffer composition and pH are Not specified for this item; refer to CoA/Spec Sheet to confirm compatibility with your workflow.

Storage and Reconstitution
  • Storage conditions (item-specific): Store at -20°C. Minimize freeze–thaw cycles. Shipments are provided in an ice chest with ice pads.
  • Light sensitivity: Protect light-sensitive conjugates after any labeling; native OVA is generally light-stable.
  • Reconstitution: Not applicable—this product is supplied as a ready-to-use solution at 6 mg/mL.
  • Aliquoting (general best practice): Upon receipt, mix gently by inversion, briefly centrifuge to collect contents, and dispense into single-use aliquots to avoid repeated freeze–thaw. Use low-protein-binding plastics or silanized glass.
  • Thawing: Thaw on ice or at 2–8°C. Mix gently to avoid foaming; do not vortex harshly. If visible particulates appear, clarify by brief low-speed spin or filtration (0.22–0.45 µm) if compatible with downstream use.
  • Stability/shelf life: Not specified for this item; refer to CoA/Spec Sheet. Actual stability depends on buffer composition, presence of preservatives/stabilizers, and handling.
  • Buffer composition and pH: Not specified for this item; refer to CoA/Spec Sheet.
  • Contamination control: Use sterile technique if asepsis is required; avoid introducing proteases. If sterility is critical, consider sterile filtration immediately after thawing, subject to compatibility.

Always consult the item-specific CoA and SDS for definitive guidance.

Structure and Identity

Ovalbumin is a soluble glycoprotein and the predominant protein of chicken egg white, supplied here as an aqueous solution at 6 mg/mL (BioReagent grade).

  • Item-specific identifiers (this lot):

    • CAS, InChIKey, SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Literature/general identity information (for ovalbumin, chicken, OVA):

    • Protein type: Non-inhibitory serpin family glycoprotein; single polypeptide chain with N-linked glycan(s).
    • Amino-acid length: ~385 residues (literature), monomeric in native conditions.
    • Apparent molecular mass: ~42–45 kDa by SDS-PAGE, heterogeneity due to glycosylation (literature).
    • Isoelectric point (pI): ~4.5–4.7 (literature).
    • Structural features: Conserved serpin fold (β-sheets and α-helices) but lacks classical protease-inhibitory activity; contains multiple lysines and carboxylates enabling conjugation chemistry; one N-glycosylation site contributing to microheterogeneity (literature).
  • 2D description in words:

    • As a macromolecule, OVA lacks a simple small-molecule 2D structure. Conceptually, it is a linear polypeptide with side-chain functional groups (amines, carboxylates, thiols in trace cysteine), and an N-linked oligosaccharide. Reactive handles for bioconjugation include ε-amines of lysines, N-terminus, carboxylates of aspartate/glutamate, and, if reduced/available, thiols. No stereocenters are definable in SMILES terms due to macromolecular nature.
Synthetic Utility

While not a small-molecule building block, ovalbumin is a versatile macromolecular scaffold for bioconjugation and materials synthesis (literature/general):

  • Functional handles:

    • ε-Amino groups (Lys) and N-terminus for acylation/urea/thiourea formation via NHS-esters, isothiocyanates, or activated carbonates.
    • Carboxylates (Asp/Glu/C-terminus) for EDC/NHS-mediated amide coupling to primary amines on ligands/polymers.
    • Limited/conditional thiols (Cys) for maleimide/haloacetyl coupling after reduction, if compatible with structural integrity.
    • Glycan oxidation generates aldehydes for hydrazone/oxime ligation and reductive amination.
  • Applications:

    • Preparation of OVA–hapten conjugates for immunoassays and antibody generation (research context).
    • Fluorophore/biotin labeling for tracer reagents in ELISA/flow cytometry.
    • Crosslinked OVA hydrogels/particles via glutaraldehyde or enzymatic crosslinkers (e.g., transglutaminase) for materials studies.
    • Adsorption on nanoparticles as a capping/stabilizing layer; creation of biointerfaces.
  • Retrosynthetic perspective:

    • OVA serves as a high-density display platform to amplify hapten valency and enhance immunochemical signals.

Item-specific buffer composition and presence/absence of interfering additives (e.g., Tris, azide) are Not specified for this item; verify compatibility before undertaking coupling chemistries.

Target Specificity

Not applicable to this product type. This item is ovalbumin (an antigen/protein), not an antibody or affinity reagent. No target specificity, clone, isotype, or species reactivity is defined for this product.

Any antigenic epitope information used in immunology studies (e.g., OVA-derived peptides) is literature context and not an attribute of this specific solution.

Precisa de ajuda para escolher o grau?

O nosso guia de seleção de graus abrange pureza, estado do estabilizador e adequação à aplicação para todas as variantes do nosso catálogo.

Ver o guia de graus BioReagent →

Deseja que lhe enviemos uma mensagem quando tivermos descontos disponíveis?

Lembrar-me mais tarde

Obrigado! Por favor, verifique a sua caixa de entrada de e-mail para confirmar.

Ops! As notificações estão desativadas.